Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Imperial receives Gates Foundation grant to develop new tests for managing AIDS treatment in developing countries

22.11.2005


Imperial College London has received a £4.9 ($8.6) million grant from the Bill & Melinda Gates Foundation to develop a simple, affordable and rapid test to measure the health of the immune system in HIV/AIDS patients in developing countries.



The ‘CD4 Initiative’ will develop an easy to use device which can measure CD4+ T-lymphocytes in HIV+ patients. The CD4 cell count measures the number of these critical disease-fighting cells in the blood, a figure which health care workers need in order to make key clinical decisions in managing HIV disease, such as when to begin or to switch antiretroviral therapy.

Current technologies for measuring CD4 counts are expensive to buy and maintain, and require a level of infrastructure and training which is often not available in many developing countries. The CD4 Initiative will develop new tests that are more appropriate for these countries based on specifications developed with health care workers in hospitals and clinics in Africa and elsewhere in the developing world.


Professor Stephen Smith, Principal of the Faculty of Medicine at Imperial College London, said: “Despite the burden of HIV/AIDS on the developing world, many of the diagnostic tools are just not accessible there due to the high cost and complexity of use. This initiative will help develop new, simple, rapid, robust and affordable tools and help remove one important barrier to the effective implementation of AIDS care in these countries.”

The principal investigator, Dr. Hans George Batz, together with the Imperial-based team will manage an R&D programme to develop these much needed diagnostics. Dr. Batz is a former Senior Vice President of Research and Development at Roche Diagnostics and has been involved with the development of the initiative for the past two years. Dr. Batz will be supported by an international steering committee of experts, a small staff and the Imperial College’s liaison to the project, Dr. Wendy Ewart. The initiative will take a project management approach, common in industry, in which multiple research teams around the world from academia, private companies and other institutions will work collaboratively under the leadership of Dr. Batz and with strict milestones and timelines to achieve.

A Research Funding Agreement for interested test developers and researchers for the CD4 Initiative will be issued in spring 2006. Inquiries about the project can be made to cd4@icl.ac.uk.

Gregg Gonsalves, from Gay Men’s Health Crisis in New York City, and who was instrumental in the establishment of the initiative, praised the Bill & Melinda Gates Foundation and Imperial College: “The CD4 Initiative is providing a bold new solution to this key problem in public health by bringing together the know-how in product development from industry with the creativity of scientists from all quarters to bring a product to the field more quickly than could be done otherwise. Healthcare workers from developing countries have been clamouring for point-of-care assays for measuring CD4 counts for several years now as management of antiretroviral therapy is difficult without these tests. We are elated that Dr. Batz, Imperial College and the Bill & Melinda Gates Foundation are responding to these urgent pleas for help.”

Tony Stephenson | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>